Teva continued to move up, and one lot of stock was called away at $42.50 via options assignment this weekend. Overall the Teva position is up nicely, but this lot will have been called away at a loss. This lot was sold at a loss, but the overall position is up nicely.
As documented in this original article , one of the main reason for liking this stock was a management team goal of over $7 eps in 2015. It is not clear to me that the company is on track for that goal any longer, and certainly the identification of a new CEO could change this type of goal. Hence, at this point I'm inclined to wait and watch with half a position in play, with a bias towards closing this position on any more upward movements.